Wednesday, 23 December 2015

Solutions in Sight for Global Nutraceuticals Market Battling with Regulatory and Consumer Confidence Issues

In February 2015, the nutraceuticals industry came in the crosshairs of Eric Schneiderman, New York Attorney General, as he launched an investigation into the efficacy and safety of herbal dietary supplements. Since then, several media reports have warned that nutraceuticals could do more harm than good – reports that stakeholders in this industry have criticized for being poorly researched. Consumers, on their part, have become slightly wary of impulsively adding nutraceuticals to their shopping carts, with consumer groups demanding more ‘clean label’ nutraceutical products.


It will take more than signature markers such as ‘organic’ and ‘natural’ for companies in the nutraceuticals industry to contend with the challenges that have cropped up on the regulatory front and have been compounded by a slew of negative media reports. The global nutraceuticals market is currently at a critical phase and the stance it adopts in the coming year will determine much of its future success, industry experts have opined. The long-term growth prospects of the global nutraceuticals market, however, look promising. Business intelligence firm Transparency Market Research, for instance, has said that the nutraceuticals market will have a valuation of US$278.96 bn by 2021. The market will reach this value with a projected CAGR of 7.3% from 2015 to 2021.

Even as the industry as a whole grapples with several regulatory and consumer-confidence issues, there are solutions in sight. Here are two opportunities that can be found in the current scenario:

Launching more natural products that align with consumers’ wellness goals: With the focusing now increasingly being on classifying what constitutes a ‘natural’ ingredient, nutraceutical makers can build consumer confidence by getting their products or key ingredients certified by reputable organizations. DNA barcode identification is expected to gain importance, especially when it comes to extracted botanical ingredients. Companies can seize this opportunity as a means to gain the trust of both consumers and regulators. In the coming years, positioning products as miracle cures for diseases and conditions would likely cause damage to the identity of nutraceutical brands. Hence, launching products that are more in line with consumers’ wellness goals with more realistic promises is the need of the hour.

Creating better integrity in the supply chain: Both functional foods and nutraceuticals need robust supply chains that can adapt to the frequent changes in regulatory mandates, ingredient stability, consumer demand, and technologies. Currently, the nutraceuticals supply chain is also bound by government regulations, with regulations in each country having a different degree of maturity. In several countries, the supply chain regulations that govern the nutraceuticals industry are not as stringent as that for the pharmaceutical sector. However, the safety and integrity of ingredients remains paramount to the nutraceuticals supply chain as well. In view of this, developing suppleness in supply chain management would be integral to success. 


While North America is currently the largest regional market for nutraceuticals, Asia Pacific is seen to be a very lucrative space too. Countries such as India and China, with their massive population base, are proving to be multibillion-dollar nutraceutical markets.

Tuesday, 22 December 2015

Social Responsibility and Pressure of Growing Emissions Makes Green Data Centers Popular amongst Top Players

In times when both developing as well the as developed countries are grappling with making compromises to cut down on emissions, the demand for green data centers has picked up at an accelerated pace.  According to a recent research report from Transparency Market Research, the global green data center market was worth US$25.8 bn in 2014 and is expected to grow at a remarkable CAGR of 30.80% from 2015 to 2022. The efforts of market leaders such as International Business Cisco Systems, Inc., Fujitsu Ltd, Dell Inc., Eaton Corporation Plc., Machines Corporation, EMC Corporation, Hitachi, Hewlett-Packard Company, Ericsson, Emerson Network Power, and Ltd and Schneider Electric (APC) are expected to bring in tremendous returns to the global green data center market.

Google to Make its 14 Data Centers “Green”

Google Inc. recently announced its intentions to make its 14 data centers across the globe “green”. The company aims to make its energy-intensive operations run on renewable energy to make its contribution towards averting dangerous effects of climate change. In a bid to achieve this goal, Google plans to acquire 76 MWs worth of wind power from Jenasen wind project of Eolus Vind AB. Google aims to triple its usage of renewable energy by 2025 and the company seems to be well on its way with these efforts. Currently, it sources 37% of its energy for data centers through renewable energy. 


The global green data center market is segmented on the basis of PUE standard, component, ownership, and geography. On the basis of PUE standard, the global green data center market is segmented into PUE 1.5 to 2, PUE greater than 2, and PUE 1 to 1.5. The components in this market are power backup, air conditioning, storage and servers, security appliances, and network. In terms of ownership, the global green data center market is segmented into external and internal. The external segment is further divided into co-location and dedicated hosting, whereas the internal segment is divided into telecommunication, BFSI, healthcare, government, energy and utility, transportation and logistics, and others such as retail. Geographically, this market is segmented into Europe, North America, Asia Pacific, the Middle East and Africa, and Latin America.

2+ PUE Segment to Lead Global Green Data Center Market

Popularly, the PUE standard greater than 2 solution is adopted by data centers. Owing to this, the PUE greater than 2 segment will continue to dominate the global green data center market. Analysts predict that the adoption of green data centers will rise across all verticals such as telecommunication, IT, BFSI, healthcare, energy and utility, transportation and logistics, and retail. Out of these, the verticals expected to witness the fastest growth will be telecommunication and IT. In terms of geography, Europe and North America are both huge contributors to the growth of the global green data center market in 2014.

Addiction Risk of Opioid Pain Management Therapeutics a Major Roadblock for Global Market

In the 2012-2018 period, the global pain management therapeutics market will be on a decline, says a market study carried out Transparency Market Research. The patent expiration of some of the blockbuster drugs such as Lyrica of Pfizer Inc. and Cymbalta of Eli Lilly & Co. is the reason for this. This, however, has been beneficial for manufacturers of generic drugs, as they have got the opportunity to launch their own formulations. 

Nevertheless, due to the extreme reduction in the revenue contribution of blockbuster drugs and loss of marketing exclusivity of these drugs, the overall market for pain management therapeutics has been adversely affected. Currently, the pain management therapeutics market is devoid of novel formulations, which has been a significant reason for the stagnation of this market.


What is Pain and what are its Health Implications?

Pain management involves alleviating pain with the aim to improve the quality of life of individuals suffering from severe or chronic pain conditions. Pain has a debilitating effect on individuals and results in loss of productivity, which in turn elevates the healthcare expenditure apportioned for pain management in a nation.  

Pain usually occurs due to tissue damage or damage to other body components, the severity of the same differing according to the condition’s severity. Usually observed in a pattern, pain is classified as per the affected body part and its duration at every cycle. Presently, the methods available for pain management are physiotherapy, chiropractor therapy, and other minimally invasive procedures; however, it is pharmaceuticals such as analgesics and painkillers that are the first line of treatment that physicians adhere to.

Drugs that are used for pain management fall in one of these therapeutic drug classes: anticonvulsants, opioids, anti-migraine agents, antidepressants, non-steroidal anti-inflammatory drugs (NSAIDS), and others. In 2011, the NSAIDS therapeutic class contributed the highest revenue to the global pain management therapeutic market, as this segment comprises some of the most commonly used over-the-counter (OTC) analgesics such as ibuprofen, aspirin, and diclofenac. 

Opioid Analgesics Reported for Addiction Issues among Americans

In the latest health tracking poll conducted by the Kaiser Family Foundation, 56% Americans reported to have a personal connection with prescription opioid analgesic abuse because someone known to them took opioid analgesic without prescription, they themselves or someone they knew was addicted to these drugs, or because someone known to them had died due an overdose.    


Currently, the U.S. is in the midst of a drug overdose epidemic, a factor that has caused death rates to increase five-fold since 1980, so much so that by 2009, the number of deaths due to drug overdose outnumbered the ones due to motor vehicle crashes. Prescription drugs such as opioid analgesics have been responsible for a significant part of these mishaps. To curb the misuse of pain management therapeutics, the consensus largely is to have a number of strategies in place that would be effective cumulatively for – providing treatment for individuals that are addicted, monitor doctors’ prescribing habits, initiating education and public awareness programs, training doctors about the appropriate use of painkillers, and encouraging people to dispose of any extra medication once their medical need was over.

Global Cosmetic Implants Market: Cheap and Defective Implants will Create a Negative Image of the Market

The demand for cosmetic implants has surged lately with growing preference for cosmetic surgeries and introduction of new surgical devices. The global cosmetic implants market was worth US$2.1 bn in 2013. Expanding at a CAGR of 5.7% during the period from 2014 to 2020, the overall cosmetic implants market is estimated to be valued at US$3.2 bn by 2020. Growing awareness about cosmetic implants, benefit of implants, and aesthetic appearance has fuelled demand from the global cosmetic implants market.

The key application segments of cosmetic implants include facial implants, breast implants, dental implants, and others including buttock, penile, and calf implants. There has been a noticeable growth in the breasts implants segment in the past couple of years. In 2013, breast implants dominated the overall cosmetic implants market. During the period between 2014 and 2020, this application segment is estimated to expand at a CAGR of 6.6%. However, growing incidences of breast implant malfunction will hamper the growth of the segment in the coming years.


Manufacturers are Often Blamed for Breast Implant Malfunctions 

The U.S. Food and Drug Administration has listed down a number of complications associated with saline-filled and silicone gel-filled breast implants such as capsular contracture, implant wrinkling, scarring, asymmetry, and infection at the incision site. Malfunctioning breast implants aggravate the complications.

Recently, it was found out that silicone implants manufactured by Silimed, the largest manufacturer of silicone implants in South America, were contaminated with particles. The Medicines and Healthcare Products Regulatory Agency (MHRA) along with other European regulators have suspended the sales of Silimed’s silicone implants. A vast majority of these silicone implants would have been used in cosmetic breast enlargement. A similar incident was reported in 2010 when it was found that Poly Implant Prothèse (PIP), one of the leading manufacturers of breast implants was not using medical-grade silicone in its devices. This increased the rate of rupture of the implants and a large number of patients across South America and Europe were affected.  

Australian Government Taking Stand against Cheap Implants

In Australia, the government is taking a firm stand against cheap breast implants in unlicensed clinics. Under new rules considered by the New South Wales government, cosmetic surgeons could be banned from offering cheap breast implants in unlicensed clinics. The government is considering making rules so that cosmetic surgeries such as breast implants, buttock implants, penis augmentation, and face lifts could only be performed in a licensed private hospital or health facility.   


While the overall cosmetic implants market is booming with the development of low cost implant devices, the threat of implant malfunction and related life-threatening complications will definitely scar the growth story of the market.

Global Cervical Cancer Diagnostic Tests Market: Prevalence of Cervical Cancer in Low-income Nations to Accelerate Growth

Cervical cancer is the third most common cancer among women and has become the second most common cause of cancer-related deaths across the globe. The deadly disease accounts for around 300,000 deaths annually. Appropriate screening methods and diagnostic tests help in early detection of cervical cancer. The global cervical cancer diagnostic tests market is estimated to expand at a CAGR of 6.10% during the period between 2014 and 2020. The overall market was worth US$5.9 bn in 2013 and is expected to reach a valuation of US$8.9 bn by 2020. 


Diagnostic Tests in High-Income Nations Curbing Occurrence of Cervical Cancer

One of the most common risk factors for cervical cancer is infection by the human papilloma virus (HPV). Other risk factors include smoking, Chlamydia infection, long-term use of oral contraceptives, family history of cervical cancer, and others. HPV testing, Pap smear tests, endocervical curettage (ECC), cone biopsy, loop electrosurgical excision procedure (LEEP), and colposcopy are some of the commonly used diagnostic tests for cervical cancer. In 2013, Pap smear tests accounted for more than 45% of the global cervical cancer diagnostic tests market owing to the high efficacy of the tests at relatively low costs. However, the low cost of Pap smear tests has not helped to decrease the number of patients affected with cervical cancer across lower income countries. 

According to a new study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research, the prevalence of infection-related cancers such as stomach, liver, and cervical cancers as well as lung, breast, and colorectal cancers has increased in low- and middle-income countries. The increasing prevalence of cervical cancer is a major concern across Southeast Asia, Sub-Saharan Africa, Central and Eastern Europe, and Latin America and the Caribbean. In high-income nations, screening programs implemented years ago have helped to curb cervical cancer rates by as much as 4% annually. 

Cervical Cancer Prevention Program in Haiti: A Concrete Step to Fight the Disease

In Haiti, around 3,000 women get cervical cancer each year and almost half of them die from the illness. In fact, the country registers the highest rate of cervical cancer across the world. Partners in Health, a Boston-based non-profit organization, has launched a two-year pilot program in Haiti to screen 20,000 women for cervical cancer and vaccinate around 6,000 girls against the strains of human papilloma virus. Zanmi Lasante, the Haitian program of Partners in Health, plans to reach around to 60,000 people, making them aware about the disease.  


In the near future, the global cervical cancer diagnostic tests market is expected to gain impetus from the demand arising from low- and middle-income countries. Though these countries lack resources to fight against the disease, development of cervical cancer prevention strategy along with donation of vaccines and other supplies will help to decrease the prevalence of the disease. For example, in Haiti, the U.S. Agency for International Development is supporting the pilot program launched by Zanmi Lasante. To avail vaccines and other supplies for the patients, the non-profit organization is coordinating with drug manufacturing company Merck & Co. 

Cloud Computing - Most Effective Way to Digitize Healthcare Systems

Compared to other economic sectors, the healthcare industry has been slow in terms of adoption of technological advances when it comes to data storage, processing, management, and interconnection of data networks between distinct and distant healthcare facilities, healthcare providers, and other stakeholders of the healthcare industry. Even today, as digitization and networking become an indispensable part of every industry, many healthcare institutions still manage the vast amount of data accumulated in everyday practices on paper records. Moreover, the limited amount of information digitized by a few institutions cannot be easily transmitted across systems.

Also, the healthcare industry has traditionally boasted highly fragmented technology infrastructure and systems. Owing to these factors, and also due to the concern over data security in the healthcare domain, the healthcare industry has shied away from the larger integration of IT solutions, making it difficult for to share a crucial data amongst the different sectors of the healthcare industry.


Cloud Computing Set to Revolutionize Healthcare Industry

However, numerous healthcare reforms are making it necessary for the healthcare industry to adopt electronic health records and modernize the traditional infrastructure to make it more compliant with digital interventions. The industry is rapidly adapting to this model, with healthcare cloud computing at the core of this transformation.

Analysts claim that cloud computing is at the core of the digital transformation that the healthcare industry is currently undergoing. There has been a huge rise in interest among healthcare companies about the vast benefits of cloud computing and the potential of this networking module in leveraging the efficiency of a number of healthcare processes. Cloud computing is expected to witness a rapid integration in the healthcare industry in the next couple of years. 

Current Pace of Adoption Reveal Healthcare Cloud’s Potential

One can gauge the rising scope of cloud in the healthcare industry from the rate at which cloud-based offerings are adopted across a variety of end-users. According to a recent market research report published by Transparency Market Research, the global market for healthcare cloud computing had a valuation of US$1.82 bn in 2011. The market is expected to expand at an exceptional 21.30% CAGR between 2012 and 2018 and reach a valuation of US$6.79 bn by 2018. 

Several healthcare practitioners and physicians across all 50 states of the U.S. already use cloud-based electronic health records (EHR). IT giants such as Microsoft, Qualcomm Life, Philips, IBM, ORACLE Corporation, and AT&T have launched highly complex and increasingly sophisticated healthcare cloud solutions spanning a number of healthcare verticals. 


Benefits that Seem to be Tailored for Healthcare Industry

For the effective digitization of the healthcare field, cloud computing is said to be the most suited solution. Here’s why:

Cloud computing modules enable on-demand access to vast storage capacities and computing applications, which are typically not achievable by conventional computing models.
Cloud computing systems support the storage and maintenance of large data sets that are typical of electronic health records or medical images.
Cloud computing modules ease the process of offloading of genomic data records from traditional healthcare data repositories.
Cloud computing modules enable the easy sharing of electronic health records among healthcare practitioners or hospitals and care delivery centers that are located at geographically distant locations, allowing timely access to data and eliminating the need for retesting.

BPA-free Canned and Preserved Food Dictates Purchase Decisions of Buyers in Asia Pacific and Latin America

The history of canned foods can be traced back to 18th century France, when military leader and emperor, Napoleon Bonaparte, wanting to ensure ample supplies of food for his armies when on the battlefield, offered a handsome prize to anyone who could devise an effective food preservation technique. This resulted in Nicolas Appert, a French cook, coming up with a technique that is popularly known today as canning. In the years that followed, the technique was improved further by Englishman Peter Durand and perfected over the years by others. 


Since then, the growth of the consumption of canned and preserved food has been anchored by the sheer convenience that such foods offer to the average consumer. From fruit and vegetables to fish and processed meat, nearly all of these foods can be canned, and are expected to create a market worth US$38.12 bn by 2021 in Asia Pacific and Latin America alone, according to Transparency Market Research. Besides offering nutrition when access to fresh food is restricted, canned products carry competitive price tags, increasing their consumer appeal.

Here’s a brief overview of the existing and future trends in the canned and preserved food Market:
 
  • BPA-related concerns have shaped the canned preserved food market and continue to do so: Although the rising popularity of canned and preserved food has largely remained unrestrained, things are changing now with consumers reading food labels more carefully and several scientific studies being conducted about how safe canned food really is. The presence of BPA in the epoxy resin lining inside cans has been criticized by health experts, and consumers are taking serious note of this aspect too. Can linings have been in used for over five decades now because they prevent the slow interaction between canned food and the metal that it is enclosed in.
  • BPA-free canned preserved foods are the future: The tendency of BPA from the can lining to migrate into canned food is, according to experts, a human health hazard. This has prompted several consumers to cut back on, or, where possible, avoid the purchase of canned preserved food. The occurrence of BPA in canned food products for babies, especially, has forced a number of companies to launch BPA-free lining in cans to sustain sales. As the demand for canned and preserved food without harmful chemicals in both preservatives and the packaging material intensifies, the market is witnessing a change. Food brands are now under immense pressure to use BPA-free cans from consumer campaigns, such as the one that’s currently being run by the Environmental Working Group.
  • Finding ways to cut back on excess salt and preservatives could help companies gain more consumers: Besides the presence of harmful chemicals such as BPA, canned and preserved foods typically have high salt and sugar content. As consumers are now more conscious of what they eat, canned foods with high salt, sugar, or preservatives content now stand a lower chance of being added to the shopping cart. Thus, opportunities will be easy to find if companies in the canned preserved food market are able to launch canned food that doesn’t contain unhealthy doses of salt and sugar. 

Despite these challenges, the growing affluence of consumers in Asia Pacific and Latin America, will mean good news for canned and preserved food companies wanting to venture into these markets.